Scheiber B, Goldenberg H
Institut für Medizinische Chemie, University of Vienna, Austria.
Z Gastroenterol. 1996 Jun;34 Suppl 3:95-8.
Hepatocytes can accumulate iron from transferrin via receptor- or non-receptor-mediated endocytosis or from non-transferrin iron complexes. The latter is several times more efficient than the transferrin-mediated uptake. Both pathways have some properties in common and mutually influence each other: Whereas on the one hand the non-permeant chelator DTPA as well as a polymer-conjugated desferrioxamine inhibit uptake of iron from transferrin, transferrin (in both forms, diferric or apo) itself inhibits uptake from the Fe(3+)-DTPA complex. At neutral pH, strong stimulation by reductant is observed, as well as inhibition by the prototropic agent chloroquine. This situation is reversed at acidic pH. Weak chelators stimulate uptake of iron from Fe-DTPA in hepatocytes. We conclude that the cell can labilize the chelate complex. The further mechanism of membrane passage is dependent on the environment. All the acquired iron can be found in ferritin.
肝细胞可以通过受体介导或非受体介导的内吞作用从转铁蛋白中积累铁,也可以从非转铁蛋白铁复合物中积累铁。后者比转铁蛋白介导的摄取效率高几倍。这两种途径有一些共同的特性,并且相互影响:一方面,非渗透性螯合剂二乙三胺五乙酸(DTPA)以及聚合物共轭去铁胺抑制从转铁蛋白摄取铁,而转铁蛋白(二价铁或脱铁形式)本身抑制从Fe(3+)-DTPA复合物摄取铁。在中性pH值下,观察到还原剂有强烈刺激作用,以及质子移变剂氯喹有抑制作用。在酸性pH值下这种情况则相反。弱螯合剂刺激肝细胞从Fe-DTPA摄取铁。我们得出结论认为,细胞可以使螯合物复合物不稳定。膜通道的进一步机制取决于环境。所有获取的铁都可以在铁蛋白中找到。